We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMW
201
DELISTED
VMware, Inc
VMW
| $11.7M | 0.1% |
102,723
-277,935
| -73% | -$31.6M |
|
202
Comcast
CMCSA
$79.1B
| $11.6M | 0.1% |
296,518
-473,404
| -61% | -$20.3M |
|
|
CCMP
203
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $11.6M | 0.1% |
66,464
+21,062
| +46% | +$3.73M |
|
204
KeyCorp
KEY
$24.3B
| $11.6M | 0.1% |
670,629
+219,683
| +49% | +$4.25M |
|
205
Charles River Laboratories
CRL
$10.9B
| $11.5M | 0.09% |
53,807
-13,723
| -20% | -$3.35M |
|
206
Dollar General
DG
$25.9B
| $11.5M | 0.09% |
46,762
+808
| +2% | +$189K |
|
207
HP
HPQ
$23.5B
| $11.3M | 0.09% |
344,522
-25,346
| -7% | -$930K |
|
208
Cogent Biosciences
COGT
$6.79B
| $11.3M | 0.09% |
1,250,889
-502,091
| -29% | -$3.43M |
|
|
KRTX
209
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $11.2M | 0.09% |
88,727
+26,632
| +43% | +$3.06M |
|
210
Insulet
PODD
$11.3B
| $11.1M | 0.09% |
51,125
+40,977
| +404% | +$9.31M |
|
211
MetLife
MET
$61B
| $11.1M | 0.09% |
176,162
+115,977
| +193% | +$7.68M |
|
212
Thomson Reuters
TRI
$39.4B
| $11.1M | 0.09% |
100,826
-30,716
| -23% | -$3.25M |
|
213
Credicorp
BAP
$30.9B
| $11M | 0.09% |
91,560
-126,040
| -58% | -$17.3M |
|
214
Revolution Medicines
RVMD
$40.2B
| $10.8M | 0.09% |
555,255
+121,051
| +28% | +$2.36M |
|
215
Nurix Therapeutics
NRIX
$2.43B
| $10.6M | 0.09% |
839,375
+74,269
| +10% | +$842K |
|
|
CERE
216
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $10.5M | 0.09% |
397,221
+145,603
| +58% | +$4.13M |
|
217
Ameresco
AMRC
$1.15B
| $10.5M | 0.09% |
230,288
| – | – |
|
218
KLA
KLAC
$275B
| $10.4M | 0.09% |
326,020
-180,820
| -36% | -$6.08M |
|
219
Wells Fargo
WFC
$261B
| $10.4M | 0.09% |
265,445
-8,491
| -3% | -$373K |
|
220
Union Pacific
UNP
$183B
| $10.3M | 0.08% |
48,116
+972
| +2% | +$221K |
|
221
Labcorp
LH
$24.3B
| $10.2M | 0.08% |
50,712
-21,251
| -30% | -$4.53M |
|
222
AT&T
T
$165B
| $10.2M | 0.08% |
486,233
-144,787
| -23% | -$2.89M |
|
223
United Rentals
URI
$71.1B
| $10M | 0.08% |
41,226
+20,157
| +96% | +$5.93M |
|
224
Keros Therapeutics
KROS
$199M
| $9.99M | 0.08% |
361,789
-58,881
| -14% | -$2.58M |
|
225
Arthur J. Gallagher & Co
AJG
$63.7B
| $9.93M | 0.08% |
60,889
+49,705
| +444% | +$8.25M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.